A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Biomedical Research


Chemspace collaborates with ChemAlive

   by Kateryna Shtereverya    258
Chemspace collaborates  with ChemAlive

Chemspace and ChemAlive (the largest repository of quantum chemical data, a Contract Research Company that develops software products to obtain accurate and reliable data on molecular properties, synthetic reactions, verification of molecules using quantum chemistry), announced the launch of the collaboration to provide accurate molecular structural information about commercial small molecules.

11 Inspiring Women Advancing Artificial Intelligence In Life Sciences

   by BiopharmaTrend    3657
11 Inspiring Women Advancing Artificial Intelligence In Life Sciences

In this post, we decided to highlight eleven entrepreneurial women, leading the way in applying advanced computational technologies, such as machine learning (ML), deep learning (DL), and other artificial intelligence (AI) components, for tackling some of the hardest challenges of science -- in drug discovery and healthcare. This list is composed in alphabetical order. 

Tzager - A Smart AI Agent For Biomedical Research

   by Nikos Tzagarakis    1110
Tzager - A Smart AI Agent For Biomedical Research

Tzager is an A.I. agent built for biomedicine research, drug discovery and personalized medicine, with the main features being Biochemical Analysis, Predictor Research/Models and Literature Review/Management. The difference with Tzager is that it is not just another deep learning algorithm trained to solve very specific problems, but the intelligence system with its own framework based on Causal Equations and Bayesian Networks.

2nd Annual Bispecifics in Discovery & Development Congress

   by BiopharmaTrend    381
2nd Annual Bispecifics in Discovery & Development Congress

Oxford Global’s 2nd Annual Bispecifics in Discovery & Development Congress will be attended by over 450 visionary leaders to network about the latest developments & participate in presentations from the areas of engineering, bioanalysis, biotherapeutics and bispecifics.

New for 2020 is the introduction of the kick-off sessions, providing an interactive experience for delegates through roundtable & panel discussions.  

13th Annual Proteins & Antibodies Congress

   by BiopharmaTrend    438
13th Annual Proteins & Antibodies Congress

Oxford Global’s 13th Annual Proteins & Antibodies Congress will be attended by over 450 visionary leaders to network about the latest developments & participate in presentations from the areas of engineering, bioanalysis, biotherapeutics and bispecifics.

New for 2020 is the introduction of the kick-off sessions, providing an interactive experience for delegates through roundtable & panel discussions.